New combo therapy aims to control advanced lung cancer
NCT ID NCT02422381
First seen Jan 31, 2026 · Last updated May 22, 2026 · Updated 13 times
Summary
This study tests a new drug, MK-3475, added to standard chemotherapy (gemcitabine) in people with advanced non-small cell lung cancer who have already tried other treatments. The goal is to find the safest dose and see if the combination helps control the cancer. Sixteen participants will be closely monitored for side effects and tumor changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Providence Oncology & Hematology Care Clinic - Eastside
Portland, Oregon, 97213, United States
-
Providence Oncology & Hematology Care Clinic - Westside
Portland, Oregon, 97225, United States
Conditions
Explore the condition pages connected to this study.